Botanix Pharmaceuticals Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • BOT

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.22
  • (As of Monday Closing)

Botanix Pharmaceuticals General Information

Description

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Contact Information

Formerly Known As
Botanix Pharma
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
ASX
Corporate Office
  • PO Box 1407
  • Subiaco
  • Perth, Western Australia 6904
  • Australia
+61 (08) 0000 0000

Botanix Pharmaceuticals Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Botanix Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.22 $0.22 $0.07 - $0.23 $344M 1.58B 4.51M

Botanix Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021
EV 218,379 106,154 33,230 42,492
Revenue 69
EBITDA (6,069) (9,440) (2,451)
Net Income (6,154) (9,544) (2,486)
Total Assets 16,440 9,656 16,492
Total Debt 0 84 195
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Botanix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Botanix Pharmaceuticals‘s full profile, request access.

Request a free trial

Botanix Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development
Drug Discovery
Perth, Australia
2 As of 2005
000.00
000000000 000.00

000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000 000000000
Melbourne, Australia
00 As of 0000
000.00 0000-00-00
000000&0

00000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Botanix Pharmaceuticals Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clinuvel Pharmaceuticals Corporation Melbourne, Australia 00 000000&0
Rigel Pharmaceuticals Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
Verrica Pharmaceuticals Formerly VC-backed Durham, NC 000 00000 000000000 00000
Dermata Formerly VC-backed San Diego, CA 0 000.00 00000000 000.00
Incyte Formerly VC-backed Wilmington, DE 0000 00000000000
You’re viewing 5 of 43 competitors. Get the full list »

Botanix Pharmaceuticals Patents

Botanix Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021904095-A0 Cbd cannabinoids and cbd cannabinoid analogues Inactive 16-Dec-2021
AU-2021901322-A0 Cbd cannabinoids and cbd cannabinoid analogues Inactive 04-May-2021
AU-2020904816-A0 Cbd cannabinoids and cbd cannabinoid analogues Inactive 23-Dec-2020
AU-2020903438-A0 Antibacterial treatment using a cannabinoid and an active agent Inactive 24-Sep-2020
AU-2019904935-A0 Cannabinoids and cannabinoid analogues with antimicrobial activity Inactive 24-Dec-2019
To view Botanix Pharmaceuticals’s complete patent history, request access »

Botanix Pharmaceuticals Executive Team (8)

Name Title Board Seat Contact Info
Howie McKibbon Chief Executive Officer
Vince Ippolito President & Executive Chairman
Bill Bosch Executive Director & Chief Scientific Officer
Matthew Callahan Founder & Executive Director
Patricia Walker Ph.D Chief Medical Adviser
You’re viewing 5 of 8 executive team members. Get the full list »

Botanix Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Botanix Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Botanix Pharmaceuticals‘s full profile, request access.

Request a free trial

Botanix Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brickell Biotech (Sofpironium Bromide Gel) 04-May-2022 000000000 00.000 Buildings and Property 00000 000
Bone Medical 27-Jun-2016 Merger/Acquisition Pharmaceuticals
To view Botanix Pharmaceuticals’s complete investments and acquisitions history, request access »

Botanix Pharmaceuticals FAQs

  • When was Botanix Pharmaceuticals founded?

    Botanix Pharmaceuticals was founded in 1984.

  • Who is the founder of Botanix Pharmaceuticals?

    Matthew Callahan is the founder of Botanix Pharmaceuticals.

  • Who is the CEO of Botanix Pharmaceuticals?

    Howie McKibbon is the CEO of Botanix Pharmaceuticals.

  • Where is Botanix Pharmaceuticals headquartered?

    Botanix Pharmaceuticals is headquartered in Perth, Australia.

  • What is the size of Botanix Pharmaceuticals?

    Botanix Pharmaceuticals has 2 total employees.

  • What industry is Botanix Pharmaceuticals in?

    Botanix Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Botanix Pharmaceuticals a private or public company?

    Botanix Pharmaceuticals is a Public company.

  • What is Botanix Pharmaceuticals’s stock symbol?

    The ticker symbol for Botanix Pharmaceuticals is BOT.

  • What is the current stock price of Botanix Pharmaceuticals?

    As of 17-Jun-2024 the stock price of Botanix Pharmaceuticals is $0.22.

  • What is the current market cap of Botanix Pharmaceuticals?

    The current market capitalization of Botanix Pharmaceuticals is $344M.

  • Who are Botanix Pharmaceuticals’s competitors?

    Clinuvel Pharmaceuticals, Rigel Pharmaceuticals, Verrica Pharmaceuticals, Dermata, and Incyte are some of the 43 competitors of Botanix Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »